NEW YORK (GenomeWeb News) – Linguamatics today said that the diabetes care company Novo Nordisk will use its text mining and natural language processing software.

Under a multi-year agreement, the Cambridge, UK-based company said that Novo Nordisk will use its I2E to mine published literature and internal information sources to provide intelligence for making research and development decisions. Linguamatics COO Roger Hale said in a statement that the I2E platform can be used to "deliver value for questions ranging from R&D to business and competitor intelligence."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.